Received Oct 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | UNK | — |
Very tired; Nauseated for days; sore muscle of arm; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of tiredness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Previously administered products included Shingrix (1st dose received on an unknown date). In SEP-2025, the patient received the 2nd dose of Shingles vaccine. In SEP-2025, less than a week after receiving Shingles vaccine, the patient experienced tiredness (Verbatim: Very tired), nausea (Verbatim: Nauseated for days) and myalgia upper extremities (Verbatim: sore muscle of arm). The outcome of the tiredness, nausea and myalgia upper extremities were not reported. It was unknown if the reporter considered the tiredness, nausea and myalgia upper extremities to be related to Shingles vaccine. It was unknown if the company considered the tiredness, nausea and myalgia upper extremities to be related to Shingles vaccine. Linked case(s) involving the same patient: US2025AMR123714 Additional Information: GSK receipt date: 24-SEP-2025 This case was reported by a patient via interactive digital media. The patient experienced soreness in the arm muscle, fatigue and persistent nausea that lasted for several days. The second dose was administered the previous week. The batch number was not provided, and we are unable to contact the reporter.; Sender's Comments: US-GSK-US2025AMR123714:Case for First dose/Same patient